Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.48 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | HPRT1 | P00492 | 3/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.41 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | GPR3 | P46089 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1247232 | 0.96 | HPRT1 (0.52) | CYP3A4ALDH1A1HSD17B10CYP2A6TSHR | |
| SCHEMBL2016968 | 0.76 | MAPT (0.64) | CYP3A4ALDH1A1TSHRHIF1ACYP1B1 | |
| SCHEMBL17511895 | 0.76 | IMPDH2 (0.40) | CYP3A4ALDH1A1KDM4ELMNAMAPK1 | |
| SCHEMBL24930 | 0.74 | LMNA (0.62) | CYP3A4ALDH1A1TSHRTDP1HIF1A | |
| SCHEMBL525523 | 0.73 | CYP2A6 (0.44) | CYP3A4ALDH1A1HSD17B10CYP2A6TSHR | |
| SCHEMBL2514730 | 0.72 | GPR3 (0.50) | CYP3A4KDM4EGPR3MAPTSMN1; SMN2 | |
| SCHEMBL2910 | 0.72 | CYP1A2 (0.44) | ALDH1A1HSD17B10CYP2A6TDP1KDM4E | |
| SCHEMBL60071 | 0.71 | MAPT (0.47) | CYP3A4ALDH1A1HSD17B10CYP2A6TSHR | |
| Phenanthrene SCHEMBL28225171 | 0.70 | ALDH1A1 (0.75) | CYP3A4ALDH1A1HSD17B10CYP2A6TSHR | |
| SCHEMBL7058875 | 0.69 | CYP1A2 (0.59) | CYP3A4ALDH1A1HSD17B10CYP2A6TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 452 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118344361-A | Fluorene-containing nitrogen-doped condensed ring resonance type organic compound and organic light-emitting device comprising same | 江苏三月科技股份有限公司 | 2024-07-16 | — | — | CN | claimed |
| CN-118324788-A | Organic electroluminescent compound and application thereof | 宁波卢米蓝新材料有限公司 | 2024-07-12 | — | — | CN | claimed |
| CN-118271356-A | Boron-containing organic compound and application thereof | 江苏三月科技股份有限公司 | 2024-07-02 | — | — | CN | claimed |
| CN-118239966-A | Organic electroluminescent compound and application thereof | 宁波卢米蓝新材料有限公司 | 2024-06-25 | — | — | CN | claimed |
| WO-2024125652-A1 | BORON-CONTAINING ORGANIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENT DEVICE PREPARED FROM SAME | 华为技术有限公司 | 2024-06-20 | — | — | WO | claimed |
| WO-2024125653-A1 | BORON-CONTAINING RESONANCE-TYPE ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME | 华为技术有限公司 | 2024-06-20 | — | — | WO | claimed |
| CN-118206576-A | Boron-containing resonance type organic compound and organic electroluminescent device comprising same | 华为技术有限公司 | 2024-06-18 | — | — | CN | claimed |
| CN-118206575-A | Boron-containing organic compound and organic electroluminescent device prepared from same | 华为技术有限公司 | 2024-06-18 | — | — | CN | claimed |
| CN-118206573-A | Boron-containing organic compound containing cyclohexane carbazole ring and organic electroluminescent device prepared from same | 江苏三月科技股份有限公司 | 2024-06-18 | — | — | CN | claimed |
| CN-118206574-A | Boron-containing organic compound and organic electroluminescent device prepared from same | 华为技术有限公司 | 2024-06-18 | — | — | CN | claimed |
| US-8557953-B2 | Polymers comprising substituted anthracenyl units, blends comprising these polymers, and devices comprising these polymers or blends | MERCK PATENT GMBH (DE) | 2013-10-15 | — | — | US | claimed |
| US-20130126855-A1 | POLYMERS CONTAINING SUBSTITUTED BENZODITHIOPHENE UNITS, BLENDS COMPRISING THESE POLYMERS, AND DEVICES COMPRISING THESE POLYMERS OR BLENDS | MERCK PATENT GMBH (DE) | 2013-05-23 | — | — | US | claimed |
| US-20120108731-A1 | POLYMERS COMPRISING SUBSTITUTED ANTHRACENYL UNITS, BLENDS COMPRISING THESE POLYMERS, AND DEVICES COMPRISING THESE POLYMERS OR BLENDS | MERCK PATENT GMBH (DE) | 2012-05-03 | — | — | US | claimed |
| WO-2012013310-A1 | POLYMERS CONTAINING SUBSTITUTED BENZODITHIOPHENE UNITS, BLENDS CONTAINING SAID POLYMERS, AND DEVICES CONTAINING SAID POLYMERS OR BLENDS | MERCK PATENT GMBH (DE) | 2012-02-02 | — | — | WO | claimed |
| US-8034941-B2 | Imidazopyridazinone and imidazopyridone derivatives, the preparation thereof and their use as pharmaceutical compositions | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2011-10-11 | — | — | US | claimed |
| WO-2010149258-A1 | POLYMERS COMPRISING SUBSTITUTED ANTHRACENYL UNITS, BLENDS COMPRISING SAID POLYMERS, AND DEVICE COMPRISING SAID POLYMERS OR BLENDS | MERCK PATENT GMBH (DE) | 2010-12-29 | — | — | WO | claimed |
| US-20090258856-A1 | IMIDAZOPYRIDAZINONE AND IMIDAZOPYRIDONE DERIVATIVES, THE PREPARATION THEREOF AND THEIR USE AS PHARMACEUTICAL COMPOSITIONS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2009-10-15 | — | — | US | claimed |
| US-7566707-B2 | Imidazopyridazinone and imidazopyridone derivatives, the preparation thereof and their use as pharmaceutical compositions | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2009-07-28 | — | — | US | claimed |
| EP-1641799-B1 | IMIDAZO-PYRIDAZINONE DERIVATIVES AND IMIDAZO-PYRIDONE DERIVATIVES, PRODUCTION THEREOF, AND USE THEREOF AS MEDICAMENTS | BOEHRINGER INGELHEIM INT (DE) | 2008-03-12 | — | — | EP | claimed |
| US-20050026921-A1 | New imidazopyridazinone and imidazopyridone derivatives, the preparation thereof and their use as pharmaceutical compositions | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2005-02-03 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090258856-A1 | IMIDAZOPYRIDAZINONE AND IMIDAZOPYRIDONE DERIVATIVES, THE PREPARATION THEREOF AND THEIR USE AS PHARMACEUTICAL COMPOSITIONS | DPP4, DPP3, DPP7 | CYP3A4 14/4885ALDH1A1 213/4885HSD17B10 1027/4885 |
| US-20050026921-A1 | New imidazopyridazinone and imidazopyridone derivatives, the preparation thereof and their use as pharmaceutical compositions | DPP4, DPP3, DPP7 | CYP3A4 12/4885ALDH1A1 239/4885HSD17B10 1093/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.